Andrew James King
Chief Scientific Officer & Head of Research and Development · Jade Biosciences, Inc.
Individual
- 2026
- Feb 14, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Andrew James King's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Redmile Group, LLC - $49.64M in ADCT purchases and sales in the last 12 months
- Casdin Partners Master Fund, L.P. - $49.54M in BLFS purchases and sales in the last 12 months
- Gary S. Guthart - $48.79M in ISRG purchases and sales in the last 12 months
- Robert B. Ford - $48.22M in ABT purchases and sales in the last 12 months
- Roger Adsett - $47.51M in INSM purchases and sales in the last 12 months
- Brian Taylor Slingsby - $46.36M in MLYS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew James King?
Andrew James King is a corporate insider, tracked as Chief Scientific Officer & Head of Research and Development of Jade Biosciences, Inc. (JBIO). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Andrew James King last file a Form 4?
The only primary Form 4 on record is dated 14 February 2026.
